<DOC>
	<DOCNO>NCT00378144</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety market sinus allergy product , Sinutab , treatment nasal congestion headache .</brief_summary>
	<brief_title>Efficacy Safety Sinutab Subjects Setting Common Cold</brief_title>
	<detailed_description>In response mandate requirement Belgium Medicines Agency - rise perforce switch Sinutab® 2 active ingredient Pseudoephedrine+Paracetamol combination - make commitment demonstrate safety efficacy Sinutab® . In agreement Medicines Agency , in-use Pharmacy-based study design demonstrate efficacy safety Sinutab® approve indication ( symptomatic relief common cold ) . This randomized , double blind , placebo-controlled , comparative phase 4 , multi-centre study parallel group Sinutab placebo . To study drug 's 'natural environment ' , community pharmacist function local investigator . Approximately 25 community pharmacist carefully select , take consideration appropriate software program use pharmacy . This implicate pharmacist medication record patient disposal use check exclusion criterion . They include subject early ( ≤ 48 hour ) cold symptom block nose headache . Subjects fulfil inclusion/exclusion criterion assign one two treatment group , accord computer-generated randomization list . A sufficient number subject randomize order enrolment , target 300 evaluable subject conclusion study . The following information collect every evening subject 7 day : symptom assessment , compliance , adverse event ability go work school .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>age 18 year report cold symptom begin ≤ 48 hour prior visit 1 score ≥ 2 nasal congestion headache use Modified Jackson Subject Evaluation Scale willing able comply schedule visit , treatment plan , study procedure evidence personally sign date informed consent document indicate subject inform pertinent aspect trial patient without electronic medication record pharmacy history hypersensitivity paracetamol pseudoephedrine lactose fever 38.0°C ( measure pharmacist ) woman fertile year use hormonal contraception intrauterine device use concomitant drug , medication treatment could interfere study drug important intercurrent medical condition base available medication record patient . ( cf . exclusion criterium 1 ) history nasal reconstructive surgery alcohol and/or drug abuse within 6month period immediately precede screen visit medication indication might point increase risk , associate study participation study drug administration may interfere interpretation study result , judgment study personnel , would make subject inappropriate inclusion participation clinical trial last three month study participation . employee clinical research center , sponsor , CRO 's contract study , immediate family member</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>